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ABSTRACT
A 3-DIMENSIONAL VASCULARIZED CARDIAC TISSUE MODEL USING
CHITOSAN NANOFIBER SCAFFOLDS
by
Ali Hussain
The development of an in vitro tissue model that can mimic the 3-dimenisonal (3-D)
cellular architecture and mosaic of myocardial tissue holds great value for cardiac tissue
engineering, modeling, and cardiovascular drug screening applications. The main
objective of this project was to develop a 3-D vascularized cardiac tissue model in vitro
for improved survival and function.
The cellular mosaic of the myocardial tissue demands the intricate integration of
an extracellular matrix-like scaffold, cellular constituents, and biological factors. The first
aim of the research was to fabricate and characterize a biodegradable chitosan nanofiber
scaffold that would resemble the extracellular matrix (ECM) physically and chemically.
Chitosan, a natural polysaccharide that shares structural homology to the ECM
glycosaminoglycans was processed into nanofibers via electrospinning to resemble the
physical nano-architecture of the ECM. The second aim was to biologically modify the
scaffold using a two step method: (1) Adsorption of fibronectin to improve cellular
attachment and migration and (2) Induction of endothelial tubulogenesis to recreate the
vascularized architecture of the myocardium. The third aim was to investigate the effect
of co-culturing cardiomyocytes with fibroblasts on cardiomyocytes’ survival and
contractility in the vascularized 3-D chitosan scaffold. This was based on the fact that
70% of the native myocardial tissue is composed of fibroblasts.
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The chitosan scaffold was characterized for its physio-chemical properties,
including in-vitro structural integrity and bio-degradability. The biomodification of the
scaffold via fibronectin adsorption improved cellular attachment, verified by staining of
actin (cytoskeletal protein) and vinculin (cell-adhesion protein). The endothelial cells
formed a network of interconnected tubes and secreted GAGs that were immobilized onto
the chitosan scaffold. The cellular studies showed that cardiomyocyte mono-cultures
resulted in islands of isolated contractions and minimal gap junction expression. In
addition, cardiomyocyte contractility was lost after four days in the mono-cultures.
However, co-culturing the cardiomyocytes with the fibroblasts promoted tissue-like
synchronous contractions that were sustained for over three weeks. Gap junction
expression in cardiomyocytes-fibroblasts co-cultures was extensive and was expressed
along the cardiomyocyte cell membranes.
Finally, to create the cardiac tissue model, the vascularized chitosan nanofibers
were impregnated with a co-culture system of cardiomyocytes and fibroblasts. Using
real-time intracellular calcium ion staining, the cardiomyocytes were observed to have
migrated through the 3-D chitosan scaffold and attained intercellular alignment to form
cardiomyocyte tubules which is a characteristic of in vivo cardiomyocytes. The
cardiomyocyte tubules were verified to contract in a synchronized and tissue-like
rhythmic manner. These results highlight the immense importance of the vascular
architecture and fibroblasts co-culture in the development of any cardiac regenerative
therapy.
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1
CHAPTER 1
INTRODUCTION

1.1 Tissue Engineering
Tissue engineering was born out of the need to replace organs or tissues that become
incompetent due to age, trauma, or pathologies. Some organs such as the heart and brain
do not possess extensive regeneration capabilities following major trauma. Organ
transplantation has been the main solution for complete organ failures. However, organ
transplantation comes with a number of major drawbacks such as donor shortage,
immuno-rejection and risk of transferring donor cancer stem cells. Other organ and tissue
replacement approaches involve autografts (transplanted from the patient‟s own healthy
tissue), allografts (transplanted from a genetically non-identical member of the same
species), and biomaterial medical device implants. These tissue replacement methods
have disadvantages which include donor site morbidity, poor integration, and
immunologic reactions.
Tissue engineering has emerged as an alternative option to organ transplantation
and replacement since it presents the opportunity to provide “off the shelf” and
immunologically safe tissue regenerative solutions that help the body heal itself.
Advances in tissue engineering have accelerated due to interdisciplinary collaboration
between researchers in biology, medicine, material science, and engineering. The
advancement and maturity of tissue engineering as a field depends on the extent of this
interdisciplinary integration, since understanding tissue-specific functionality and repair
mechanism is a very complex process. Furthermore, every tissue is unique in its cellular
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composition and architecture, physiological requirements, extracellular niche, and many
other biological, physical, and chemical parameters. Figure 1.1 illustrates the key factors
that are involved in designing and developing a tissue engineered construct.
Biomaterial Scaffold:
Natural or synthetic polymers,
ceramics, metals.
Hydrogels, nanofibers, freeze
dried sponges,
Cellular Composition:
Stem cells, co-culturing, feeder
layers

Tissue Engineered
Construct

Signaling Biomolecules:
Proteins, growth factors,
hormones

Figure 1.1 The main components of a tissue engineered construct.

1.2 Myocardial Infarction and Cardiac Tissue Engineering
Heart disease is a preeminent cause of death in the world, responsible for about 40% of
human mortality. Annually in the United States, 550,000 new cases are diagnosed and
about $33 billion is spent on dealing with heart failure [1]. There is a large variety of
pathologies that cause heart failure such as ischemic heart disease which is sometimes
accompanied with acute myocardial infarction, hypertension, and primary myocardial
disease. Ischemic heart disease followed by an episode of acute myocardial infarction is
the most frequent cause of left-sided cardiac failure [1].
One of the major causes of end stage heart failure is myocardial infarction. When
the blood vessels supplying the physiologically demanding myocardium tissue become
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occluded, the downstream tissue experiences ischemia. The metabolic strain on the
myocardial tissue will lead to cardiomyocyte demise which is medically labeled as
myocardial infarction. More importantly myocardial infarction leads to myocyte slippage.
The term myocytes slippage refers to the sliding of bundles or singular myocytes along
the longitudinal axis of the tissue lamina [2]. The necrosis of the cardiomyocytes caused
by the ischemia activates multiple neurohormonal and inflammatory pathways, depicted
in Figure 1.2, that lead to the degradation of the fibrillar collagen network connections
that provide the structural integrity to the myocytes bundles.

Figure 1.2 Flowchart representations of the pathophysiological events that develop
during ventricular remodeling. ECM: extracellular matrix; RAAS: rennin-angiotensinaldosterone system; CO: cardiac output; SVR: system vascular resistance; LV: left
ventricle; and AII: angiotensin II. [3]
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The replacement of the damaged myocardium with a non-contractile fibrous scar
tissue compromises heart contractile efficiency. In addition, the collagenous extracellular
matrix is weakened leading to a thin heart wall, ventricular dilation and remodeling. The
damage to the heart wall is permanent because following extensive cell loss, the
myocardium does not possess intrinsic regenerative capability [4]. Furthermore, the
myocardium contains very limited and sparse number of cardiac stem cells making native
regeneration a localized and ineffective solution for a large infracted region [5].
The ventricular remodeling that occurs following myocardial infarction is
characterized by increase in cardiomyocyte cell volume: myocytes hypertrophy and the
excess deposition of collagen fibers in the myocardial extracellular environment. These
physiological and physical changes in the cellular and acellular components of the
myocardium serve to compensate for the non-contractile scar tissue formed in the
infarcted heart. However, this excessive and pathological secretion of ECM components,
mainly collagen, leads to systolic and diastolic dysfunction of the ventricles since it
affects cardiac conduction capabilities [6]. As a result, the remodeled heart undergoes
hypertrophy and increased collagen secretion that eventually predisposes it to end stage
of congestive heart failure.
Currently, several medical treatment regiments are indicated to control the
ventricle remodeling or slow the pace of progression to heart failure. Pharmacological
therapeutics reduces the heart‟s work load via diuretics and nitrates. In addition, humoral
factors can be blocked, via ACE inhibitors or B-blockers, since they are over activated in
heart failure [7]. Interventional therapy, such as implanting pacing devices can be
performed to control electrical/mechanical asynchrony. Nonetheless, pharmaceutics and
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surgery fall short from preventing progression to end stage heart failure [8]. Ultimately,
heart transplantation is the final option for end-stage heart failure. However, due to the
scarcity of heart donors and the confines and complications linked with immune
suppression and rejection researchers are turning towards cardiac tissue engineering to
discover effective solutions to revive the distressed heart.
Seminal studies published in the early 1990s depicted long-term survival and
differentiated phenotype of transplanted skeletal myoblasts in the ventricular
myocardium [9-11]. These studies paved the way for cardiac tissue engineering and shed
light on the possibility of replacing the injured myocardium with healthy cells. Cell
transplantation procedures into the injury site are dependent on the cell species and the
transplantation method to provide optimal engraftment of the cells. Every cell in the body
requires a niche which is characterized by unique physical, chemical, and biological
parameters that supports its survival and induces optimal cellular functionality. It has
been reported that more than 90% of the cells injected into the ventricular wall are lost
since the cells do not undergo engraftment immediately when introduced into the native
heart tissue [12].
Hence, the goal of in vitro myocardial tissue engineering, as seen in Figure 1.3, is
to create a physically, chemically, and biologically designed scaffold that the cells can
adhere to and function on, until they engraft within the native tissue. The ex vivo
generation of a 3D myocardial tissue employing cells, biomaterials, and bio-molecules
provides a temporary niche for the cardiomyocytes to become functionally mature and
improve the chances of engraftment post-implantation.
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Figure 1.3 Potential tissue engineering methods for the treatment of myocardial
infarction. (1) Polymer restraints can be used to maintain the left ventricles geometry and
slow ventricular remodeling. (2) In vitro tissue engineering utilizes biomaterial scaffolds
impregnated with cells in vitro and then transferred to the epicardial infarcted region. (3)
In situ tissue engineered involves the local injection of a biomaterial, or biomaterial +
cells or only biological factors. [13]

1.3 Current State of the Art
The objective of cardiomyocyte-based engineered tissue constructs is to produce a
contractile tissue-like patch that can be used to restore the contractility and pumping
efficiency of the infracted region. Ideally, these constructs have to be clinically relevant
in terms of thickness (~1.5cm for human myocardium), mechanical stiffness (10-20 kPa
at the start of diastole and 200-500 kPa at the end of systole), and high cell density (2 x
108 cells/cm3) consisting of aligned myofibers [14-17]. None of the cardiac constructs
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currently generated have reproduced fully clinically relevant constructs in terms of
thickness or functionality. The following are some promising examples of in vitro cardiac
constructs that have been implanted in vivo.
Zimmerman et al. fabricated a ring-shaped cardiac construct using neonatal
cardiomyocytes seeded on collagen I gel mechanically conditioned using a bioreactor.
The construct exhibited spontaneous contractions and was shown to improve cardiac
performance after implantation [18, 19]. However, the construct was 1-4mm thick and
histological integration (desmosomes and gap junctions) between the implant and the
host tissue was not confirmed.
Leor et al. developed cardiac grafts by culturing cardiomyocytes on freeze-dried
alginate scaffolds and implanted them into the infracted myocardium. The observations
demonstrated a significant increase in angiogenesis of the graft but no change in cardiac
contractility [20]. Okano et al. produced cardiomyocyte cell sheets by culturing them on
thermosensitive polymer poly (N-isopropylacrylamide). These polymers are hydrophobic
and cell adhesive at 37°C; however, when the temperature is dropped to 32°C, they
hydrate and become hydrophilic causing the cells to detach as a single cellular sheet [21].
These cellular sheets have been shown to electrically couple and pulse in a synchronized
manner. In addition, four sheets were layered to form a pulsatile cardiac tissue grafts that
was then implanted subcutaneously into rats and shown to survive three months in vivo
[22]. Most of the developed cardiac constructs use only cardiomyocytes seeded on a
biomaterial to implant in the infraction site.
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1.4 Biomaterials
In my opinion, the main requirements for a biomaterial are biological performance and
biodegradability. The author defines biological performance as the materials‟ ability to
elicit the cells to perform the desired function without any adverse side-effects. An
example of an adverse side-effect is inflammatory responses, the biomaterial must be a
non-foreign body-reaction forming substance, i.e., its presence in the body should not
trigger an immune response wherein macrophages start to fuse together forming foreign
body giant cells that encapsulate the biomaterial and prevent it from performing its
intended function [23]. Biodegradability defines the material‟s decomposition via natural
in vivo processes. The degradation by products should be non-toxic and easily removed
from the body.
Typically, biomaterials can be divided into two broad categories: natural and
synthetic materials. Both categories have with advantages and disadvantages. Proteins are
great natural materials since they possess the ability to exhibit receptor-binding amino
acid sequences to the cells. They are also susceptible to cell-mediated proteolytic
biodegradation. However, they have complex purification procedures and present the risk
of disease transmission [24]. On the other hand, biologically inert and non-biodegradable
synthetic materials provide batch-to-batch uniformity and can have manufactured tailored
properties.
The choice and modification of the biomaterial is dependent on the intended
application. For tissue engineering, each tissue or cell type will require certain chemical
and physical requirements from the biomaterial to enable the optimum functioning of the
engineered graft. The effect of the biomaterials on cellular function is a vital aspect in
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ensuring that the cells can function when transplanted to the site of injury. For instance,
nerve cells have been shown to exhibit significant enhancement in neurite extension
when cultured on piezoelectric biomaterials [25, 26]. These piezoelectric biomaterials
such as poled polyvinylidene fluoride contain transient surface charges that have been
attributed to the improvement in neurite growth [27]. Similarly, skin regeneration is
improved by the use of an upper silicone membrane which maintains a certain moisture
level at the wound site, accelerating the healing process and induces skin re-growth [28].
1.4.1 Chitosan
Chitosan is a copolymer consisting of D-glucosamine and N-acetyl-D-glucosamine
monomers derived from natural chitin by basic deacetylation. Because of chitosan‟s
solubility in acidic solutions, it is used in more applications compared to chitin [29].
Recently

chitosan‟s

biodegradability,

non-toxicity,

wound-healing

properties,

biocompatibility, antimicrobial activity, and low immunogenicity have highlighted its
potential in numerous industries ranging from waste-management, cosmetics,
pharmaceutics, medicine and textiles [30-32]. Chitosan‟s use as a biomaterial is driven by
its (1) economic cost (2) structural homology to the ECM GAGs as seen in Figure 1.4 (3)
positive charge allowing it to interact with negatively charged GAGs and growth factors
(4) anti-microbial properties and (5) derivation from chitin, the second most abundant
natural polymer [33].
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Figure 1.4 The structural homology of the natural glucosaminoglycans (a through d) to
chitosan (e) [34]
In terms of tissue engineering applications, chitosan has been used in skin [35],
bone [36], and neural [37]. To date, chitosan has not been used in cardiac tissue
engineering as seen in Table 1.1 which is referenced from a 2010 published review on
myocardial tissue engineering [38].
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Table 1.1 List of Biomaterials Used in Cardiac Tissue Engineering
Materials
Natural materials
Gelatin
Matrigel
Collagen
Alginate
Fibrin glue
Collagen and Matrigel
Synthetic materials
Polyglycolic acid (PGA)
Poly(glycerol sebacate) PGS
Poly(e-caprolactone-co-L-lactide) (PCLA)
Poly(N-isopropylacrylamide) (PIPAAm)
Polyurethanes (PU)
Poly(glycolide-co-lactide) (PLGA)
PGA-co-poly-4-hydroxybutyrate (PGA/P4HB)

References
[39]
[40]
[41]
[20]
[42]
[43, 44]
[45, 46]
[47]
[48]
[22]
[49]
[50]
[51]

1.4.2 Scaffolds
Scaffolds provide a 3-dimensional physical structure where the cells can attach, migrate,
generate their own extracellular matrix, and proliferate into a functional tissue according
to the scaffold‟s shape. During the early 1980s, Bissell et al. published a groundbreaking
report coining the term “dynamic reciprocity” to articulate the delicate interplay between
the extracellular matrix‟s physical and chemical cues on the cell‟s cytoskeleton, nuclear
matrix and ultimately gene expression [52]. Hence, the scaffold‟s design in terms of
architecture and the biological performance is critical to the survival and optimum
cellular functionality as seen in Figure 1.5. The scaffold also provides structural stability
for the newly forming and developing tissue until it is capable of functioning in its native
extracellular matrix.
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Figure 1.5 Graphical representation of a 3D biomaterial cellular scaffold portrays the
signals that can be transferred to the cells via the physical architecture or biological
components that ultimately control cell fate and functionality. The architectural
components include but are not limited to the permeability, stiffness, degradability, and
dimensionality of the structure. The biological components refer to proteins, growth
factors or other bioresponsive molecules (molecules that elicit biological responses from
cells) that can be incorporated within the scaffold to induce or activate certain molecular
pathways. [53]
The best scaffold for the cells is the natural extracellular matrix generated by the
cells themselves. Thus it comes as no surprise the extensive attention given to replicating
the architecture and biological conductance of the natural extracellular matrix. The
natural extracellular matrix can be divided into two main categories: interstitial/stromal
and basement membrane [54]. Each type is unique in its architecture and biological
composition. The interstitial extracellular matrix provides the intercellular milieu,
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however the basement membrane is a sheet-like basolateral substratum that delineates
cellular structures.
The architectural elements of the extracellular matrix include a network of fibrous
protein components including collagen, fibrin, and elastin and a hydrogel matrix of
glycosamino glycans such as hyaluronic acid, heparin sulfate, and keratin sulfate. Hence,
the extracellular matrix can be visualized as a fiber reinforced hydrogel. The biological
functionality of the extracellular matrix arises from its:
1. Ability to sequester, store, and present soluble growth factors and regulatory
molecules [55].
2. Availability of multidomain proteins such as fibronectin, laminin, vitronectin, and
entactin. These proteins have numerous functions such as cell attachment,
activation of developmental processes, and cell differentiation [56].
3. Control of cell shape and cytoskeletal mechanics by changing the extracellular
matrix stiffness [57].
Combining the architectural and biological aspects of the cell-extracellular matrix
interaction, it is evident that a coupling between the insoluble architectural ECM factors
and the chemical and biological soluble ECM factors tightly control the cells fate,
survival, migration, proliferation, and differentiation [58].Furthermore, each tissue‟s
ECM will vary significantly in terms of composition, physical structure, and biological
components according to the developmental, functional, and healing processes. It is
important to realize the function of the malleability of the ECM in response to
physiological needs. For example, during cardiogenesis, the acellular ECM is surrounded
by endocardial and myocardial cell layers. The endothelial cells differentiate into
primordial heart valves in response to an increase in ECM synthesis by the myocytes.
The primitive mouse ECM has been shown to retain bone morphogenic proteins and
other transforming growth factor-beta family of cytokines in an inactive form until
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activation is triggered by ECM degradation which induces endothelial cell migration and
the advancement of cardiac development [59]. On the other hand, an increase in synthesis
by fibroblasts during cardiac injury causes excess collagen deposition and fibrosis [60].
Hence, since the optimal scaffold for the cells is their native extracellular matrix; the
engineered scaffold should interact with the natural extracellular matrix and enable the
presentation of the ECM to the cells until complete engraftment in the host tissue.

1.5 Cell Sourcing
The biggest hurdle in cardiac tissue engineering is the quest for an appropriate cell source.
The heart tissue is one of the most densely populated tissues, 40 million cardiomyocytes
per gram of native myocardium [61]. Hence, the primary cells currently used in cardiac
tissue engineering research are proof-of-concept substitutes. Cardiac tissue engineering
cannot be translated into a clinically relevant therapy until an appropriate cell source has
been found.
The following options are some of the cell sources currently being investigated
for cardiac regenerative therapies:
1. Adult stem cells found in the bone marrow [62], peripheral blood [63], umbilical
cord [64] and adipose tissue [65] have been observed to give rise to
cardiomyocytes.
2. Resident progenitor cells in the heart have the potential to differentiate into
functional cardiomyocytes [66].
3. Alternative to adult stem cells, embryonic stem cells have been shown to
spontaneously differentiate into cardiomyocytes [67], however the major
drawback of embryonic stem cells is their potential to form tumors and difficulty
to differentiate into pure cell lineages.
The cell sourcing issue in cardiac tissue engineering remains to be the main
determining factor on whether adult cardiac regeneration ever becomes a reality. Table
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1.2 provides up to date cell sources that are currently being investigated to populate the
injured heart.
Table 1.2 Review of the Cell Sources Used in the Treatment of Myocardial Diseases
Cell source
Skeletal myoblasts

Differentiation potential
Terminal differentiation

Marrow mesenchymal
stem cells
Bone marrow cells

Cardiomyocytes, vascular
endothelium
Cardiomyocytes, vascular
endothelium
Vascular endothelium

Endothelial progenitor
cells
Resident cardiac stem
cells
Embryonic stem cells

Cardiomyocytes

Induced pluripotent
stem cells

Pluripotent

Source: [38]

Pluripotency

Current usage
Repopulate scar tissue and
improve LV function
Repopulate damaged myocardium
Repopulate damaged myocardium
Neo-vascularization to prevent
myocardium apoptosis and LV
remodeling
Improve cardiovascular function
Revascularization and regenerate
damaged myocardium
Repair damaged heart
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1.6 Objectives
This research‟s overall aim is to engineer a myocardial tissue model construct that can
mimic the 3-dimensional cellular architecture and mosaic of myocardial tissue. This
cardiac tissue model can potentially be used in myocardial tissue regeneration or utilized
as a platform technology for diagnostics, drug screening or therapeutics. The motivation
is to attain extended cardiomyocyte viability and functionality in a 3-dimensional in
vitro tissue model. This study hypothesizes that co-culturing primary cardiomyocytes
with fibroblasts will improve cardiomyocyte longevity and functionality in vitro. Specific
aims are listed below:
1. The fabrication and characterization of chitosan nanofibrous scaffolds.
2. Biomodification of the chitosan nanofibrous scaffolds to create a vascularized
cellular niche.
3. Improve cardiomyocyte longevity and functionality by co-culturing with
fibroblasts. Impregnate the biomodified chitosan scaffolds with cardiomyocytes
and fibroblasts co-culture and assess cardiomyocyte functionality.
The uniqueness of the approach taken in this research is the use of all three of the
main cell types present in the myocardium: cardiomyocytes, fibroblasts, and endothelial
cells to recreate the in vivo myocardial cellular niche. Moreover, the three cells types are
not simply seeded on the scaffold, rather the scaffold will first be vascularized using
endothelial cells to recreate the rich vasculature bed that perfuses the myocardial tissue
and then the vascularized scaffold will be impregnated with a co-culture of
cardiomyocytes and fibroblasts.
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The novelties in this research are:
1. This is the first report to investigate the potential of chitosan nanofibers in the
field of cardiac tissue regeneration.
2. This is the first report to induce vascularization on chitosan nanofibers.
(provisional patent filed)
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CHAPTER 2
FABRICATION AND CHARACTERIZATION
OF ELECTROSPUN CHITOSAN SCAFFOLDS

2.1 Introduction to Electrospinning Chitosan
Electrospinning is a polymer processing technique that generates fibers in the micro- to
nano-dimensions. Nanofiber scaffolds have are widely used in tissue engineering because
of their architectural resemblance to the natural extra-cellular matrix. Furthermore,
electrospinning provides a quick cost-effective and relatively simple processing method
to produce ultra-fine nanofibers into non-woven oriented or non-oriented matrices. A
typical electrospinning setup includes a metal needle connected to a syringe, a pump flow
rate controller, a DC voltage supply and a grounded plate collector as shown in Figure
2.1

Figure 2.1 A typical electrospinning setup for the fabrication of a non-woven randomly
oriented fiber matrix.
The theory behind the electrospinning process is that fiber formation occurs when
the electrostatic forces created between the metal needle and the grounded collector plate
has overcome the surface tension of the polymer solution. As the intensity of the

19
electrostatic forces increase, the polymer solution at the tip of the needle will elongate to
form a Taylor cone. When the electrostatic forces overcomes the surface tension, the
polymer solution gets drawn out as a taylor cone from which a linear region extends and
undergoes a whipping process wherein the solvent evaporates very quickly depositing
nano- to micro-scale fibers on the metal collector. There are many factors that affect the
formation of electrospun fibers: (1) Solution properties: molecular weight or
concentration which affects viscosity, electrical conductivity, polarity and surface tension
of solution. (2) Electrospinning chamber properties: Voltage supply intensity,
electrospinning distance, solution flow rate, humidity, and temperature [68].
The first published reports on electrospinning of pure chitin and chitosan were
performed by Min et al. and Ohkawa et al. respectively in 2004 [69, 70]. Chitosan
becomes water-soluble in acidic pH <6 by the protonation of the amine on the
glucosamine group; this cationic nature poses a major challenge in electrospinning. Due
to chitosan‟s polyelectrolyte behavior, hydrophilic nature, and water retaining properties;
chitosan has the spontaneous capability to form gels in acidic pH which increases its
viscosity and hinders the electrospinning process [71]. To overcome this challenge, high
concentrations (80% to 100% v/v) of acids are usually used to electrospin chitosan
ranging from moderately weak acids such as acetic acid to trifluoroacetic acid [69, 72,
73].
This section of the research focused on the fabrication of the chitosan nanofibers
and their physical, chemical, and thermal material analytical characterization.
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2.2 Methods
2.2.1 Rheological Measurements of Chitosan Electrospinning Solution
Commercially available medium molecular weight chitosan, purchased from SigmaAldrich (448877-250G, Batch 07918TE) was dissolved at 8% (w/v) in 100%
trifluoroacetic acid (TFA) (Fisher, O4901-500) by stirring for 15 hours at 45C.
Methylene chloride (MeCl) (Fisher, D143-1) was added drop wise into the chitosan
solution, while stirring, to the final (v/v) ratio of TFA: MeCl, 80:20. The viscosity of the
chitosan electrospinning solution was measured using Rheometric Scientific (T.A.
Instruments) Stress Rheometer SR 200 25mm PPS parallel plate at room temperature
(25C - 30°C). The viscosity measurements were performed at various time points after
initial mixing of the chitosan in the TFA (2, 15, 24 hours and 7 days).
2.2.2 Chitosan Nanofibers Fabrication and Diameter Characterization
The electrospinning apparatus used to generate the chitosan nanofibers included a syringe
pump to pump the chitosan solution through an 18 gauge, 1 inch long metal needle at 34ml/hour. A high voltage power supply of 25-30kV was attached to the needle and a
grounded aluminum collector plate was positioned 25-30cm from the tip of the needle.
The chitosan solution was placed in the syringe and electrospun at room temperature
(25C to 30°C) and relative humidity of (20-30%). The chitosan nanofibers were placed
under vacuum for 24 hours to remove the remaining solvent from the nanofibers. The
fiber diameter distribution was determined using scanning electron microscopy (SEM)
using a LEO 1530 Gemini microscope. The chitosan nanofibers were carbon sputtercoated and examined by the SEM. Diameters of 195 fibers, 65 fibers from three
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electrospun samples were measured. Sigma Scan Pro software was used to analyze the
average fiber diameter.
2.2.3 Mechanical Tensile Testing
The Young‟s modulus and ultimate tensile strength were determined using an Instron
uniaxial tensile testing equipment model 3343. The chitosan nanofiber matrices were
prepared into rectangular strips (60x20mm). The relative humidity was 20-30%, gauge
was set to 20mm and cross head speed of 10mm/min was used. All the strips were tested
until complete rupture with a 100N load cell at room temperature (25-30°C).
2.2.4 Fiber Swelling Assay
The chitosan nanofiber mats were prepared into squares (20x20x0.15 mm3) and
neutralized in a basic solution composed of 15N ammonium hydroxide and 100% ethanol
(1:1 v/v) for 30 minutes. The nanofibers were then washed with deionized water three
times, each time for 10 minutes. The nanofibers were placed in phosphate buffer solution,
PBS; pH 7.2 and incubated at 37°C and 10% CO2. The PBS solution was changed every
3 days. At certain time points (days 1, 7, 14, 21, 28) the nanofibers‟ diameter distribution
was analyzed by SEM. The fiber diameters were quantified using Nikon Imaging
Solutions (NIS)-elements basic research software (v.3-448). Three chitosan sample
duplicates was used for each time point and a total of ~190 measurements were used to
analyze the diameters.
2.2.5 In Vitro Lysozyme Degradation Assay
The chitosan nanofiber matrices were prepared into squares (20x20x0.15 mm3) and
neutralized as mentioned above. The degradation of the chitosan nanofibers was assessed
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by incubating them in egg-white lysozyme (MP Biomedicals LLC, CAT#100834)
dissolved at 4mg/ml in PBS, pH 7.2, at 37°C and 10% CO2. At specific time intervals
(days 7, 14, 21, 28) the matrices were removed from the lysozyme solution, washed with
water, vacuum dried for 24 hours, and weighed. The degradation profile was illustrated
using the weight loss percentage of the dried sample before and after degradation.
2.2.6 Fourier Transform Infrared Spectroscopy
Fourier transform infrared (FTIR) analysis was done using the Perkin Elmer FTIR-ATR
100 series. The spectra were analyzed in the 400-2000cm-1 range with a resolution of
4cm-1 and 30 scan repeats. Unprocessed chitosan powder, film cast from the
electrospinning solution and electrospun nanofibers were analyzed. The chitosan films
were cast by pouring 2ml of the chitosan electrospinning solution in an uncoated p35
Petri dish and allowed to air dry in the chemical hood for over 48 hours.
2.2.7 Thermal Analysis via DSC and TGA
Thermogravimetric analysis (TGA, TA instruments model Q50, New Castle, DE) was
performed in an inert atmosphere (dry nitrogen, flow rate 40ml/min), 10°C/min heating
rate and maximum temperature of 300°C. Differential scanning calorimetry (DSC, TA
instruments Q100, New Castle, DE) was performed in sequential double scans on each
sample. The first scan was to remove the water in the sample which was followed
immediately by the second scan.
2.2.8 Molecular Organization Analysis via XRD
Chitosan powder, cast film and electrospun nanofibers were analyzed by X-ray
diffraction (XRD) using an X‟pert Pro Diffractometer (PW3050/60, Philips, Netherlands).

23
Monochromatized Cu K (1.54056A) X-ray source was used to irradiate the samples with
a step size (2-theta) of 0.05°, scan step time of 1.0 sec and 2-theta range of 0-60°. The
operating voltage and current were 45kV and 40mA, respectively.
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2.3 Results
2.3.1 Fiber Fabrication and Diameter
At 2hrs after mixing 8% (w/v) chitosan in 100% TFA, the viscosity of the solution was
12,700cP (Figure 2.2). The addition of the organic solvent MeCl to the solution caused
the viscosity to dramatically drop to 1,400cP. It was observed that the viscosity of the
electrospinning solution decreased as time progressed. Attempts at electrospinning the
solution at 2hrs failed because the viscosity was too high for the solution to be smoothly
pumped out of the needle.

Figure 2.2 The viscosity of chitosan solutions using two solvents, (black: TFA, red: TFA
and Methylene Chloride) post initial mixing. Graph insert is a close-up of the 2-24hrs.
The optimized viscosity of the electrospinning solution that enabled the
generation of smooth bead free fibers from chitosan was around 300 cP; this was
achieved after 12-15 hours of stirring. Beyond this stirring window, the solution is not
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viscous enough and electrospinning attempts led to the formation of droplets onto the
metal collector. The optimized chitosan fiber matrices had an average fiber diameter of
188±59nm and mat thickness ~150-200µm (Figure 2.3).

Figure 2.3 SEM images of vacuum dried electrospun pure chitosan prepared from 8%
(w/v) chitosan dissolved in trifluoroacetic acid/methylene chloride (8:2) solution. (A)
5000 X original magnification (B) 50,000X original magnification. (C) Fiber diameter
distribution of the chitosan nanofibers. Average diameter and standard deviation was
188± 59nm.

2.3.2 Instron Tensile Testing
The uniaxial tensile properties of the chitosan nanofiber matrices were examined using an
Instron. The stress-strain profile, seen in Figure 2.4, of the matrices resulted in an
evolving stress-strain modulus. During the initial phase of the tensile loading, the elastic
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modulus was 20.4MPa ± 5. Following further tensile loading onto the matrices, the
stress-strain modulus increased significantly to 62.3MPa ± 5. The matrices ruptured at an
ultimate tensile strength of 2.20 ± 0.37.

Figure 2.4 The stress-strain profile of electrospun pure chitosan nanofibers under uniaxial tensile stress applied using an INSTRON apparatus at 25°C.

2.3.3 Fiber Morphological Stability
The structural stability of the fibers was monitored during PBS incubation over 28 days.
The freshly formed fibers (0 day incubation) displayed an average diameter of 188±59nm.
Table 2,1, demonstrates that the increase in fiber average diameter and the diameter
distribution range.
Table 2.1 Average Fiber Diameters of the Pure Electrospun Chitosan Nanofibers
Incubated in Phosphate Buffered Solution at 37°C and 10% CO2
PBS incubation days
Fiber diameter (average ± std dev)
0
188nm±59
1
258nm±106
7
356nm±213
14
442nm±172
21
446nm±213
28
405nm±143
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The widening of the diameter distribution range suggests the presence of a range
of swelling properties within the electrospun chitosan fibers. Hence, some fibers swell
faster than others, as seen in Figure 2.5 which shows the distribution electrospun chitosan
fiber diameters at several time intervals up to 28 days of PBS incubation.

Figure 2.5 (A) Graphical representation of the widening of the electrospun chitosan fiber
diameter distribution during 0, 1, 7, 14, 21, 28 days of PBS incubation. (B) SEM of
electrospun chitosan fiber after 28 days of PBS incubation showing the increased fiber
diameter distribution, 20, 000X original magnification. (50 measurements were
performed from 3 replicate samples for each time period).

2.3.4 Fiber In Vitro Degradation Assay
The degradation study demonstrated significant changes in the rate of degradation with
time. The chitosan fiber matrices showed the highest rate of degradation during the first 7
days by displaying 30% dry weight loss. The matrices lost a further 13% dry weight
during the following 21 days. The degradation profile shown using percent weight loss in
Figure 2.5A demonstrates that the degradation rate is initially rapid followed by a slow
degradation phase. The SEM micrographs (Figure 2.6B) of the chitosan matrices treated
with lysozyme for 28 days depict that some of the fibers have maintained their smooth
cylindrical morphology while others have degraded into textured, beaded film structures.
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Figure 2.6 (A) Graphical representation of dry weight loss percentage of electrospun
chitosan nanofibers during in vitro bio-degradation assay using lysozyme. (Blue: no
lysozyme, red: with lysozyme) (B) SEM of the electrospun chitosan nanofibers after 28
days incubation in lysozyme solution, 20,000X original magnification.

2.3.5 Fourier Transform Infrared Spectroscopy
The FTIR spectra of the chitosan film and electrospun fibers show the presence of CH
and CH2 peaks at 719-793 cm-1 and NH amine peak at 834cm-1 which are absent from the
unprocessed chitosan powder spectra (Figure 2.7). The NH amide band was shifted
downward from 1560-1553 cm-1 in the powder to 1525-1515cm-1 in the electrospun
fibers, similarly the CO amide band shifted from 1673-1668cm-1 to 1648-1640cm-1.
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Figure 2.7 FT-IR analysis of the unprocessed (a) chitosan polymer powder, (b) cast film
from the electrospinning chitosan solution, and the (c) electrospun chitosan nanofibers.

2.3.6 Thermal Analysis
Changes in heat flow in the sample and degradation temperatures were studied using
DSC and TGA. The unprocessed chitosan powder and the electrospun chitosan fibers
were compared. DSC profiles demonstrated broad endothermic events with peak maxima
at 90°C for the electrospun chitosan fibers and 140°C for the chitosan powder during the
first scan. The second DSC scan illustrated a change in heat flow at 120°C, and a broad
endothermic event at 230°C followed by another event at 250°C. The chitosan powder‟s
second DSC profile demonstrated a change in heat capacity at 200°C and an endothermic
event at 270°C (Figure 2.8A).
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TGA showed an initial weight loss that plateaus in both the electrospun chitosan
fibers and powder. Further weight loss of the electrospun chitosan fibers started at a
temperature of ~150°C as compared to the powder which started at ~280°C (Figure 2.7B).

fibers

powder

A

fibers

powder

B

Figure 2.8 (A) Differential Scanning Calorimetric analysis and (B) Thermal
Gravitational Analysis of the unprocessed chitosan powder and the electrospun chitosan
nanofibers.

2.3.7 X-ray Diffraction
As depicted in Figure 2.9, the unprocessed chitosan powder had two broad peaks at 2theta = 10.2° and 19.9°, in addition to a broad background halo. The cast film from the
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chitosan electrospinning solution resulted in one broad peak at 2-theta= 19.9°. The
electrospun chitosan fiber XRD pattern resulted in the lowest intensity peak at 2-theta =
19.9, two very sharp and intense peaks at 2-theta = 38.3° and 44.5° and the lowest
amount of background halo.

Figure 2.9 X-ray diffraction patterns of unprocessed chitosan powder, chitosan film and
electrospun chitosan nanofibers.

2.4 Discussion
The goal of this section of the research was the fabrication and characterization of the
physical, chemical, and thermal properties of electrospun chitosan.
Electrospinning is a complex process affected by many parameters including the
nature of the solvent‟s volatility and polarity, polymer concentration and molecular
weight, surface tension, pump flow rate, voltage applied, electrospinning distance,
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temperature, and humidity. The viscosity of the electrospinning solution is vital in
forming bead-free continuous fibers because very low viscosities imply that the solution
is materially deficient to produce a continuous fiber. Solutions with very high viscosities
would clog the metal needle and prevent the continuous flow of the polymer solution.
The polymer solution‟s viscosity is influenced by the intermolecular interactions between
the polymeric chains. Chitosan‟s high viscosity is caused by the strong and numerous 3dimensional networks of hydrogen bonds between the amine and hydroxyl groups [74,
75]. TFA is used to dissolve chitosan because it forms amine salts with chitosan‟s C2amine groups [76]. The addition of the organic solvent methylene chloride causes a
significant drop in the viscosity. This can be attributed to the disruption of the hydrogen
bond network allowing the mobilization of the polymer chains under the influence of the
electrical field.
The reduced viscosity allows the chitosan solution to flow continuously out of the
capillary tip enabling the formation of continuous bead free fibers. The continuous drop
in viscosity of the chitosan-TFA solution is attributed to the acid hydrolysis of the
chitosan which is accompanied by the solution changing color from yellow to dark brown.
This is due to the release of free glucoasmines which causes browning of the solution
[77] . The acid hydrolysis of chitosan decreases the molecular weight, which in turn
decreases the density of polymer entanglements present in the solution. These polymer
entanglements are necessary for holding the polymer chains together to form a coherent
fiber. As a result, with increase polymer degradation, the solution‟s spinnability decreases
preventing the formation of a continuous fiber. Hence in electrospinning of chitosan form
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an acidic solvent there exists a time period (12 to 15 hours in our study) prior and beyond
which chitosan could not be electrospun.
The random orientation of the electrospun chitosan nanofibers leads to the
deposition of fiber entanglements within the matrix. These entanglements get engaged
when the fiber matrix experiences tensile stress giving rise to a characteristic stress-strain
modulus behavior. In Figure 2.4, the Young‟s modulus of the chitosan nanofibrous
matrix increased as the stress applied increased. The increase in the modulus can be
explained by the increase in the number of fiber entanglements engaged as more and
more fibers are being pulled on. Ultimately, the chitosan nanofibers rupture causing the
entanglements to fail.
Due to chitosan‟s high hydrophilicity and likelihood to form hydrogels, the
structural integrity of the chitosan nanofibers was investigated in PBS for 28 days.
Hydrophilicity is a vital feature of chitosan‟s appeal as a biomaterial as it enhances the
production of the extracellular matrix and enhances homeostasis of wounds by
accelerating blood clotting [78]. The incubation of the chitosan nanofibers in PBS
resulted in swelling of some of the fibers while maintaining the cylindrical fibrous
morphology. Some fibers swelled at a rapid rate, while others swelled at a slower pace or
not at all. The variety in swelling behavior of the chitosan nanofibers can be explained by
the differences between the chitosan inter-molecular hydrogen bonds. The fibers that
exhibit inter-sheet hydrogen bonding prevent the chitosan from swelling and retaining
water. While the fibers in which the inter-sheet hydrogen bonding is absent will swell and
retain water [31].
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Chitosan can be degraded by a variety of enzymes in vitro such as chitinase,
chitosanase, lysozyme, collagenase and pectinase [79-81]. In vivo, lysozyme attacks
chitosan‟s acetylated residues and hydrolyze its glycosidic bonds. Lysozyme is released
from phagocytic cells such as macrophages and neutrophils [82]. The degradation byproduct of chitosan are aminosugars which are non-toxic, non-immunogenic, and
completely absorbed by the body through glycosaminoglycans and glycoprotein
metabolic pathways or excreted [83]. Figure 2.6 A show that the fibers undergo an initial
phase of rapid degration followed by a phase of slower degradation. SEM micrographs
shown in Figure 2.6 B, depict that some fibers have completely lost their cylindrical
morphology and transformed into a film like structure, while others have maintained their
fibrous structure. The bi-phasic degradation model of the electrospun chitosan can be
explained using the fiber swelling, XRD, and FTIR data. Correlating the degradation and
swelling test results, it can be suggested that the fibers that exhibit rapid swelling also
exhibit faster degradation rates.
FTIR spectra of the electrospun chitosan nanofibers show bond vibration peaks of
the amine and alkane groups that were absent in the unprocessed chitosan powder. This
suggests that the 3-dimensional hydrogen bond network that immobilized these groups in
the chitosan powder was disrupted during electrospinning. In addition, the electrospun
chitosan‟s amide bands have shifted to higher frequencies compared to the chitosan
powder indicating that the polymer chains have changed their physical organization
compared to the powder [84].
DSC results showed that the electrospun chitosan nanofibers have a change in
heat flow at a lower temperature compared to the unprocessed chitosan powder. This
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implies that the chitosan polymer chains in the unprocessed powder are physically
organized in a different manner compared to the electrospun chitosan nanofibers. The
thermal degradation behavior of chitosan is complex as it consists of dehydration,
deacetyaltion and chain scission. The unprocessed chitosan powder started thermal
degradation at a higher temperature compared to the electrospun chitosan fibers. This can
be attributed to the fact that the electrospun chitosan fibers which were prepared from the
TFA containing solution have undergone some degradation. During the electrospinning
process, the acid hydrolysis of the chitosan chains and the remaining acidic solvent
within the fibers will catalyze the degradation of the chitosan nanofibers as compared to
the chitosan powder, as seen in Figure 2.8.
The XRD data, Figure 2.9, supports the FTIR data as it indicates a more ordered
molecular organization in the electrospun nanofibers as compared to the unprocessed
chitosan powder. There are six polymorphs that have been proposed for chitosan: tendon,
annealed, 1-2, L-2, form I and form II [85].The two peaks with lattice angles of 10.2° and
19.9° are attributed to the equatorial (100) and (020) reflections seen in the „L-2‟ chitosan
polymorph [86]. The L-2 organization of chitosan chains is significantly disrupted in the
electrospun chitosan nanofibers because of the high speed elongational flow and rapid
vitrification that occurred during electrospinning. Electrospinning altered the molecular
arrangement of the chitosan polymer chains and organized them with two uniform dspacings. However, some of the L-2 morphology still remains within the electrospun
samples. This diversity in molecular organization within the chitosan nanofibers might
contribute to the bi-phasic degradation profile and varying fiber swelling rates.
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2.5 Conclusion
Pure electrospun chitosan nanofibers were fabricated and analytically characterized. The
electrospinning of pure chitosan fibers was successfully reproduced by optimizing the
stirring time of the chitosan in the TFA solution, which is correlated to the viscosity of
the solution. The characterization results suggest that electrospinning of chitosan alters its
molecular organization in a manner that produces two main types of polymer
confirmations One type of polymer confirmation allows fiber swelling and rapid
degradation by lysozyme. However, the other polymer confirmation swells and degrades
at a much slower rate. Based on these observations, electrospinning of chitosan affects its
behavior as a scaffolding biomaterial in vitro.
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CHAPTER 3
CHITOSAN BIOLOGICAL PERFORMANCE AND VASCUALRIZATION

3.1 Introduction
Many cellular processes, including the differentiation, proliferation, and survival, of
adhesion dependent cells are affected by their attachment to the extracellular matrix. The
adhesion and interaction of cells to their surrounding is mediated by a variety of
transmembrane receptors, integrin being one of the most heavily studied and understood
adhesion receptor. Integrins not only attach the cells to the extracellular matrix but they
also act as a signal relay center where extracellular mechanical cues are internalized via
interaction with cytoskeleton actin microfilaments and intermediate filaments [87].
However, these transmembrane integrin adhesion links also serve as a signaling pathway
cluster where focal adhesion enters activate various signaling molecules including FAK,
Src, and paxillin [88].
Unique amino acid sequences, for example arginine-glycine-aspartic acid (RGD),
present in the extracellular matrix mosaic of proteins provide the binding site for
integrins. Hence, the integrin-mediated adhesion of cells onto biomaterials is dependent
on the ability of the extracellular matrix proteins to adsorb and adequately present these
amino acid binding sites to the cells. The biomaterial surface characteristics that affect
protein adsorption include hydrophilicity/hydrophobicity, chemistry, surface charge and
charge density, texture, crystallinity, and rigidity [89-92].

There are numerous

techniques to improve the cytocompatibility of biomaterial surfaces including adsorption,
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blending and crosslinking of proteins; however the main objective of those techniques is
to present extracellular matrix motifs to the cells to enhance integrin binding.
One of the most interesting biomaterial induced cell processes is the
tubulogenesis of endothelial cells on Matrigel. This biomaterial induced phenomenon is
the result of culturing endothelial cells on a gel material that consists of harvested rat
chondrosarcoma extracellular matrix [93]. Matrigel contains many extracellular matrix
proteins such as laminin-1, collagen IV and peptides C16 and A13 which are known to be
proangiogenic signals [94]. However, it is unlikely that Matrigel will ever reach the
patient‟s bedside since it is very costly and tumor derived.
As a matter of fact, a major challenge in the engineering of any tissue, especially
myocardial tissue, is the incapability of providing sufficient blood supply immediately
post implantation. Engineering grafts for thick complex tissues such as cardiac tissue
require adequate vasculature to sustain physiological requirements since the diffusion
limit for oxygen is 100-200 m [95]. This challenge is intensified when engineering a
physiological demanding tissue such as the myocardium. The native myocardial tissue is
supplied by rich vasculature which is necessary to quench the immense demand for
oxygen and nutrients required for its continuous vigorous contractile activity.
In addition to serving as conduits for blood supply, endothelial cells are vital for
promoting cardiomyocyte survival and function [96]. Neureglin secreted by endothelial
cells affect cardiomyocyte survival, proliferation and hypertrophic growth through the
phosphatidylinositol-3-kinase-AKt pathway [97-99]. Furthermore, cardiac endothelial
cells influence cardiomyocyte contractility by the secretion of numerous modulators,
such as nitric oxide which affects cardiomyocyte inotropism [100], endothelin causes
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cardiomyocyte constriction [101] and platelet derived growth factor

(PDGF) affect

cardiomyocyte development [102].
Several approaches have been investigated to vascularize cardiac grafts. Capsi et
al. seeded human Embryonic Stem Cell derived endothelial cells (hESC-EC) or Human
Umbilical Vein EC (HUVEC) on PLLA/PLGA porous scaffolds along with embryonic
fibroblasts and were able to depict some vascularization [97]. Radisic et al. covalently
immobilized angiogenic factors VEGF and angiopoietin-1 onto collagen sponges
resulting in an increase in infiltration of murine embryonic heart endothelium cells into
the scaffold and an elongated cellular morphology [103]. Okano et al. were able to show
in growth of vasculature from HUVEC sheets into fibroblast sheets that were stacked on
top of each other [104]. Dvir et al. were successful in showing that maturing their cardiac
Matrigel incorporated constructs on a blood rich membrane, rat omentum, enabled the
formation of functional blood vessel networks [105]. Matrigel is a biological mixture of
the basement membrane extracted from rat chondrosarcoma ECM, which makes it
unfavorable for patient use [93]. While these vascularization attempts have led to limited
success, the goal of engineering a favorable technique to generate 3-D vasculature
networks within scaffolds remains elusive.
This section of the research focused on the improvement of chitosan‟s
cytocompatibility by adsorbing fibronectin on its surfaces. In addition, a novel technique
of inducing tubulogenesis in endothelial cells was developed by using fibronectin and
chitosan‟s hydrogel-like nanofibers‟ characteristics. This is a very important and
translatable part of the research as the vascularization of biomaterial scaffolds can be
used as a platform technology for vascularization of many regenerative constructs.
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3.2 Methods
3.2.1 Fibronectin Adsorption on Chitosan Films and Nanofiber
In order to evaluate fibronectin adsorption on chitosan, 24-well tissue culture dishes were
coated with 1% chitosan and dried for 1 hr before neutralization with 0.2 M ammonium
hydroxide. Fibronectin (Sigma) solutions of different concentration (0 g/ml, 0.6 g/ml,
1.2 g/ml, 5 g/ml, 10 g/ml, and 20 g/ml in deionized water) were added into the
dishes and incubated for 1 hour. The chitosan nanofibers were treated with fibronectin
solution (10 g/ml) for 1 hour at 37C and 10% CO2 incubator. The relative amount of
adsorbed fibronectin was characterized by fluorescent staining intensity analysis using
the primary rabbit anti-fibronectin (Sigma) and the secondary anti-rabbit IgG, alexa fluor
488 (Invitrogen).
3.2.2 Cell Seeding on Chitosan Film and Nanofibers
Primary ventricular cardiomyocytes were isolated from 1-day-old neonatal Wistar rats
(Charles River Laboratories, MA) using a collagenase procedure as described previously
[106]. Briefly, the pups are anesthetized by spraying with ethanol and incubating in the
refrigerator for 10 minutes. The beating heart is excised from a small abdominal incision.
The hearts are washed with PBS and minced into small pieces. The minced heart pieces
are then treated in 0.12% collagenase II solution in a series of digestion incubations each
for 15 minutes and the dissociated cells are collected in 5% Horse serum. The harvested
cells are then separated according to Percoll gradient. The cardiomyocyte layer is
cultured on 0.1% gelatin coated dishes.
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Cardiomyocyte culture medium consists of DMEM (Gibco, Gaithersburgh, MD)
with

10%

FBS

(Biowest,

Miami,

insulin/transferrin/selenious acid (ITS; 5

FL),

2

g/mL, 5

mM

L-glutamine

(Gibco),

g/mL, 5 ng/mL, respectively)

(Invitrogen), and 2% penicillin/streptomycin (Gibco). Murine 3T3-J2 fibroblasts
(purchased from Howard Green, Harvard Medical School, Boston, MA), were maintained
in 60-mm tissue culture dishes in DMEM plus 10% FBS and 2% penicillin and
streptomycin. Rat heart microvascular endothelial cells (MVEC; purchased from VEC
Technologies, Rensselaer, NY) and rat liver sinusoidal endothelial cells (LSEC; isolated
from adult rat liver), were maintained in DMEM supplemented with 10% FBS, 2 mM Lglutamine, ITS, 2% penicillin/streptomycin, and 10 ng/mL vascular endothelial growth
factor (VEGF, R & D Systems, Minneapolis, MN). Culture medium was changed every
three days.
For the 2-D cell cultures, the chitosan or chitosan/Fibronectin adsorbed films were
prepared in 24-well tissue culture dishes, as described in Section 2.2. Cells were seeded
at a density of ~25,000 cells/cm2 on the films in 0.5 mL of culture medium. For 3-D cell
cultures, the nanofibers were treated with fibronectin solution (10 g/ml) for 1 hour to
adsorb fibronectin on the fibers. The nanofibers were then soaked in culture medium for
about 5 minutes prior to cell seeding. The suspended cells (fibroblasts, cardiomyocytes,
or endothelial cells) in culture medium were directly seeded at a density of ~300,000
cells/cm2 on separate chitosan nanofibrous mats with 300 l of medium and incubated for
about 1 hour before adding further medium to allow for better cell entrapment and
attachment. The mats were incubated in a 10% CO2, 37 oC incubator and the medium was
changed every 3 days.
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3.2.3 Tube Formation on Different Types of Gels
Endothelial cell tube formation was tested on two different gel substrates: collagen gel
and Matrigel

TM

. 0.1% (w/v) gelatin was prepared in deionized water. The gelatin

solution was warmed in a 37°C water bath before use. Collagen gel (BD Biosciences)
was prepared by mixing 1.2 mg/ml collagen solution with 10X DMEM at 9:1 ratio (v/v)
at ice temperature and keeping it on ice until use. The Matrigel solutions (BD
Biosciences) were maintained at ice temperature until use.
150µL of each gel type substrate was added into a well of a 24-well plate and the
gels were incubated at 37°C and 10% CO2 for 45 minutes to allow for gelation. The EC
cells were cultured in endothelial cell medium, containing DMEM supplemented with
10% Fetal Bovine Serum, 2% Penicillin/Streptomycin, 10g/ml Vascular Endothelial
Growth Factor (VEGF) and 1X Insulin-Transferrin-Selenium (ITS). The cells were
cultured at 37°C and 10% CO2 in p60 tissue culture dishes and harvested at 75-90%
confluency.
For harvesting cells, the p60 tissue culture dishes were washed twice with 3mL of
Phosphate Buffer Solution (PBS) and then incubated with 1mL 1X trypsin (SAFC
Biosciences, cat # 59428C-500ml) at 37°C and 10% CO2 incubator for 10 minutes. The
cells detached from the surface of the tissue culture dish after the incubation period. With
the help of a pipette, the surface of the tissue culture dish was further washed with the
trypsin-cell suspension to ensure the detachment of any remaining attached cells. In
addition, the trypsin-cell suspension was gently mixed with a pipette to cause the
disintegration of any cells that might have detached as clusters. The trypsin was then
neutralized by the addition of 5mL of the endothelial cell media and centrifuged at room
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temperature for 10 minutes at a speed for 850 revolutions per minute. The supernatant
was discarded and the cell pellet was re-suspended in 1mL of endothelial cell media.
The cells were counted using a hemocytometer and seeded on top of the gel
substrates at a density of 10,000 cells/cm2. The total volume of endothelial cell media
added to the wells was 250µL. Tube formation was checked using light microscopy every
24 hours of culture. Tube formation was classified as the alignment of the endothelial
cells behind each other in a train-like fashion and the physical transformation of the cells
into elongated or tubular morphologies. Light phase images were captured using Nikon
camera (model number 150365). The media was changed every three days.
3.2.4 Tube Formation on Chitosan Nanofibers
The chitosan nanofibers were prepared into squares (20x20x0.15 mm3) and neutralized in
a basic solution composed of 15N ammounium hydroxide and 100% ethanol (1:1 v/v) for
30 minutes. The nanofibers were then washed with deionized water three times, each
time for 10 minutes. The fibers were then incubated for 1 hour in 10µg/ml human
fibronectin solution (BD Biosciences). The fibers were washed with endothelial cell
media prior to cell seeding. Endothelial cells were seeded at a density of 200,000
cells/cm2 directly on the fibronectin-coated chitosan nanofibers.
3.2.5 Cell Attachment and Spreading Evaluation
The samples were washed with PBS and fixed with 4% paraformaldehyde for 20 minutes
at room temperature. After washing with PBS, the samples were permeabilized in 0.2%
Triton X-100 in PBS for 10 minutes. The samples were then washed with PBS and
incubated in blocking buffer (PBS/10% FBS/1% BSA) for 30 minutes. The primary
antibody was then added and incubated for 60 minutes at room temperature. The samples
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were washed with PBS and then incubated with the secondary antibody for 60 minutes.
The samples were then washed and examined with fluorescence microscopy (Nikon). The
primary antibodies used were mouse anti-vinculin (Millipore, 1:200 dilution), mouse
anti- -sarcomeric actin (Invitrogen, 1:50 dilution), and rabbit anti-connexin 43 (Sigma,
1:1000 dilution). The secondary antibodies used were donkey anti-mouse IgG, alexa fluor
488 and donkey anti-rabbit IgG, alexa fluor 594 (Invitrogen).
For the distribution of actin microfilaments, cells were stained by incubating fixed
and permeabilized cultures with 0.1 g/mL rhodamine phalloidin (Sigma) for 30 min. In
some cases, cells were counterstained with 4, 6-diamidino-2-phenylindole (DAPI;
Invitrogen) for nuclear staining. In order to verify the adsorption of fibronectin onto
chitosan, the samples were stained for 1 hr at room temperature with rabbit antifibronectin. After washing twice with PBS, the samples were incubated with alexa fluor
488 conjugated anti-rabbit IgG, and washed twice with PBS. Cell viability on the
nanofiber scaffolds was examined by a live/dead viability/cytotoxicity kit (Invitrogen).
3.2.6 Scanning Electron Microscopy (SEM)
The cell seeded nanofibers scaffolds were examined with SEM. The samples were fixed
with 2.5% gluteraldehyde for 24 hours at 4 oC. The samples were then washed with PBS
and serially dehydrated with 50%, 70%, and 100% ethanol for 15 minutes each. This was
done to allow gradual dehydration of the cells preventing loss of cellular structural
integrity. The samples were then vacuum-dried for about 6 hours. The samples were
coated with carbon and observed with SEM.
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3.2.7

Live/Dead Cell Staining

Calcein AM/Ehidium homodimer live/dead cell stain was used to visualize the cells on
the 2-D gel substrates and 3-D chitosan nanofibers. To stain the cells, the cell culture
media was changed and Calcein AM and Ehtidium homodimer (Invitrogen L3224) were
added at 1µL/ml of media to the cultures. The cultures were then placed at 37°C and 10%
CO2 for 10 minutes prior to capturing images using the fluorescent microscope. Nuclear
DAPI stain was also used to stain the nuclei of the cells by adding 1µL /ml of culture and
incubated for 10 minutes.
3.2.8

Safranin-O Staining

Safaranin-O was used to stain the sulfated glucosaminoglycans present in the chitosan
mats. The cell seeded mats were treated with 4% paraformaldehyde (Electron
Microscopy Sciences, 15715-S) for 20 minutes. 2mL of the Safranin-O dye was then
added to the culture dishes and incubated at room temperature for 10 minutes. The
chitosan mats were then washed with water at least three times. Light images were then
captured using the Nikon light microscope.
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3.3 Results
3.3.1 Fibronectin Adsorption on the Chitosan Scaffolds
It is known that cellular attachment to biomaterials is enhanced by immobilizing
fibronectin by adsorption. To establish the concentration at which chitosan is saturated by
fibronectin adsorption, immunofluorescent staining of adsorbed fibronectin using varying
concentrations (0 g/ml to 20 g/ml) was performed. Figure 3.1 illustrates an increase in
observed fluorescence intensity with fibronectin concentration, which suggests that
fibronectin adsorption on chitosan coated wells is dependent on the concentration of the
fibronectin solution. There was a steady increase in the amount of adsorbed fibronectin as
the concentration increases and the adsorption plateaus beyond 10 g/ml. As a result, the
10 g/ml solution was used to adsorb fibronectin on the chitosan nanofibers for improved
cell adhesion.

Figure 3.1 Fibronectin adsorption on chitosan. (A) Relative fluorescence intensity of
adsorbed fibronectin on chitosan coated tissue culture dishes at various fibronectin
concentrations by immunofluorescence staining. (B and C) Light phase and
immunofluorescence staining for anti-fibronectin of chitosan nanofibers adsorbed by
fibronectin solution (10µg/ml) at 200X original magnification.
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3.3.2 Effect of Fibronectin on Cellular Morphology and Cytoskeletal Organization
In order to investigate the effect of fibronectin immobilization on chitosan material in cell
cultures, the morphology and cytoskeletal protein distribution of endothelial cells and
cardiomyocytes were monitored on 2-D chitosan films with and without fibronectin
adsorption. The optical microscopy and fluorescent staining in Figure 3.2A (endothelial
cells) and 3.2C (cardiomyocytes) indicates that the cells maintain a rounded morphology,
minimal vinculin (focal adhesion) expression, and a diffused F-actin cytoskeletal
organization when cultured on chitosan film. In contrast, the cells cultured on fibronectin
coated chitosan films demonstrated enhanced cellular spreading, significant increase in
vinculin expression and a well organized fibrous F-actin cytoskeleton (Figures 3.2B and
3.2D).
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Figure 3.2 Morphology, Vinculin (focal adhesion) expression, and cytoskeletal F-actin
organization of (A and B) endothelial cells (EC) and (C and D) cardiomyocytes cultured
on chitosan and chitosan-fibronectin coated tissue cultured dishes (day 2 cultures). Light
phase contrast and immunoflourescence staining images for Vinculin (green),
cytoskeletal F-actin (red), and nuclear DAPI (blue) of endothelial cells and
cardiomyocytes . 200X original magnification.

Similarly, the endothelial cells seeded on non-coated chitosan nanofibers retained
their circular morphology and did not attach to the nanofibers. Figure 3.3 depicts SEM
micrographs of the endothelial cells seeded on coated and non-coated chitosan nanofibers.

49
It is clear that the cells extend pseudo pods and attach onto the nanofibers when they are
coated with fibronectin.

A

C

B

D

Figure 3.3 (A and B) SEM micrographs of non-coated and fibronectin coated chitosan
nanofibers seeded with endothelial cells (MVEC) after 1 day culture. 5,000X original
magnification. (C and D) Live cell calcein AM stained endothelial cells cultured on noncoated and fibronectin coated chitosan nanofibers after 1 day culture. 200X original
magnification.

3.3.3 Characterization of Cellular Behavior in Chitosan Nanofibrous Mats
Assessment of cellular viability and morphology was performed to evaluate the
cytocompatibility of electrospun chitosan nanofibrous mats and their potential as cellular
scaffolds. Three day culture of fibroblasts on the chitosan nanofibers demonstrated
endothelial cells, and cardiomyocytes were seeded onto fibronectin coated chitosan mats
and cultured over three weeks. Figures 3.4A-C depict the live-dead staining of fibroblasts
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cultured on the chitosan nanofiber scaffolds, indicating the chitosan nanofibers do not
adversely affect cell viability. Some cells formed filopodia-like extensions to attach to the
fibers, assisting them in spreading inside the chitosan nanofibrous scaffold, Figure 3.5 A.
In addition, the SEM images exhibit the formation of a film-like material surrounding the
densely seeded areas, indicating the secretion and immobilization of cell secreted ECM
components.

Figure 3.4 (A) Live cell calcein AM staining (B) Dead cell Ethidium homodimer staining
and (C) Light phase image of 3T3-J2 fibroblasts cultured on chitosan-fibronectin
adsorbed nanfoibers for 4 days. 200X original magnification. (D-F) SEM images of
fibroblasts, cardiomyocytes, and endothelial cells cultured on chitosan-fibronectin
adsorbed nanofibers after three weeks of culture.
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B

C

Figure 3.5 (A) SEM micrograph of fibroblasts cells after 9 day culture in chitosan
nanofibers showing the extension of pseudopods to attach to physically attach to the
fibers, 5000X original magnification. (B) SEM micrograph of fibrous extracellular
matrix extruding from the cell surface to the chitosan nanofibers, 40 000X original
magnification. (C) Immunofluorescent staining of cytoskeletal f-actin (red) and nuclear
DAPI (blue) to illustrate fibroblasts day 9 cellular distribution within the nanofibers,
100X original magnification.

3.3.4 Effect of Gel Type and Cell Density on Tube Formation from Endothelial
Cells.
Endothelial cells (LSEC) cultured on Collagen gel did not results in any tube formation at
either cell densities as seen in Figure 3.6. However, when LSEC were cultured on
Matrigel, the low density culture (50,000 cells/cm2) resulted in disconnected tubes as
opposed to the high density system which resulted in an interconnected tubular network.

52

Collagen Gel

Matrigel
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High Seeding
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Figure 3.6 Light phase images of LSEC cultured on collagen gel and Matrigel at low and
high cell densities. (A) collagen at 50 k cells/cm2 (B) Matrigel at 50 k cells/cm2 (C)
collagen at 125 k cells/cm2 (D) Matrigel at 125 k cells/cm2. All images were captured
after 24 hours of incubation at 37°C and 10% CO2. 40X original magnification.
LSEC cultured on chitosan nanofibers were observed to form interconnected
networks over three weeks of culture periods. Capillary-like network formations
increased over time and they remained structurally stable and viable up to 21 days as seen
in Figures 3.7 A-D.
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Figure 3.7 Calcein AM live cell staining of LSEC cultures in chitosan nanofiber mats
(A) day 1 (B) day 7 (C) day 14 and (D) day 21. 40X original magnification.

It is evident from Figures 3.7 and 3.8 that the endothelial cells seeded on the
fibronectin coated chitosan nanofibers were able to migrate and develop intercellular
alignment that enabled the cells to attain connected tubular morphologies.
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Figure 3.8 LSEC tube-like network structures in the chitosan nanofibers 80 k cells/cm2
on day 14 (A) Calcein AM live cell stained image, 200X (B) Scanning electron
micrograph, 10,000X and (C) Safranin-O stained image of cell seeded scaffold (D)
Safranin-O stained image of scaffold without cells (control), 200X.

3.4 Discussion
The goal of this section of the research was to improve the cytocompatibility of chitosan
using fibronectin adsorption and induce tubulogenesis of endothelial cells.
Fibronectin adsorption on chitosan improved cellular attachment significantly.
This was possible because of chitosan‟s cationic nature which does not cause the loss of
the biological activity of the adsorbed fibronectin. Proteins not do denature when
adsorbed on hydrophilic surfaces such as cationic chitosan as their confirmation is not
altered significantly [107]. Hence the fibronectin was adsorbed on the chitosan films
which significantly improved cell attachment and spreading.

The improved cellular
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attachment was successfully accomplished on the chitosan nanofibers as well. It is clear
that the fibronectin adsorbed chitosan nanofibers induce the cells to form pseudopods and
attach to the nanofibers. Furthermore, the cells seeded on the nanofibers began to migrate
through the inter-fiber voids, secrete their own extra cellular matrix and form a coherent
3-dimensional tissue-like network. This migration of cells through the scaffold was
clearly demonstrated using tubulogenesis which is the intercellular alignment of cells to
form interconnected tubes.
Vascular morphogenesis, among other complex cellular processes, is orchestrated
via interaction between the cell's genetic information and the interstitial extracellular
matrix (ECM). The ECM functions as a dynamic scaffold providing malleable biological
and physical cues that coordinate the cells‟ fate. In this study, first we investigated the
effect of two different gel substrates and cell seeding densities on one of the stages of
vascular morphogenesis: intercellular alignment into tubes. In addition, 3-dimensional
tube formation was studied on fibronectin adsorbed chitosan nanofibers.
Collagen gel and Matrigel were the two gel substrates investigated. Gelatin is
derived from denatured natural collagen.

Collagen is the fibrous structural protein

component of the natural in vivo ECM. Matrigel is the reconstituted soluble basement
membrane extract derived from the Engelbreth-Holm-Swarm (EHS) sarcoma. This
laminin-rich basement membrane gelatinous substrate contains other ECM components
such as collagen IV, heparin sulfate proteoglycan, entactin/nidogen, and growth factors
[108].
As seen in Figure 3.6, LSEC resulted in intercellular alignment only when they
were cultured on Matrigel. These results might be caused by differences in the biological
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nature of cellular attachment to the gel substrates. Matrigel is rich in laminin which
induces endothelial cell alignment and capillary tube formation by interacting with the
cell using the YIGSR sequence in the B1 chain and RGD sequence in the A chain [109].
Furthermore, it has been reported that cellular traction on the Matrigel surface generates
narrow tracks on the gel surface along which the endothelial cells can migrate to align
themselves into tubes [110].
Interconnected tubular formation was evident when the cell seeding density was
increased from 50,000 cells/cm2 to 125,000/cm2 on 100% Matrigel as evident in Figure
3.6. The endothelial cells‟ morphogenesis into the vascular phenotype requires the
coordination of multiple behaviors including migration, proliferation, intercellular
alignment and adhesion and the generation of a lumen [111]. Endothelial cells‟ behavior,
survival and proliferation is heavily dependent on the integrin mediated interactions with
basement membrane components within the Matrigel [112].
In addition, tube formation was investigated on the chitosan nanofibers without
the use of Matrigel. Figure 3.7 clearly demonstrates that LSECs have migrated across the
nanofibers and have aligned themselves linearly to form interconnected network tubes.
The intercellular alignment of LSEC on the nanofibers could be the result of physical
cues from the architecture of the nanofibers. As the endothelial cells attach and migrate
across the chitosan nanofibers they can cause traction by pulling on the nanofibers and
communicate mechanically with neighboring cells about their spatial organization. The
cells can sense the mechanical signals through their transmembrane ECM receptors such
as focal contact sites [113]. The phosphorylation of integrin by protein kinases at these
focal contact sites can induce cytoskeletal reorganization which might mediate tubular
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morphogenesis [114]. Hence, mechanochemical cues caused by the cells traction on the
nanofibers trigger morphogenic signaling that mediates tube formation.
Nevertheless, the influence on the morphogenesis of endothelial cells by the
substrate‟s architecture is one of the factors amongst an elusive matrix of factors that
synchronize vascular morphogenesis. To our knowledge this is the first report of
endothelial tube formation on 3-dimensional chitosan nanofibers without the use of the
most commonly used angiogenic gel substrates such as Laminin and Matrigel.

3.5 Conclusion
The biological performance of the chitosan nanofibers was successfully improved via
fibronectin adsorption. The migration of endothelial cells and intercellular alignment into
tubes in the chitosan nanofibers exhibits the immense potential of using chitosan
nanofibers as vascularized tissue engineered constructs or in vitro tissue models. In the
next section, the vascularized chitosan nanofibers will be impregnated with a
cardiomyocyte-fibroblast co-culture system to recreate the myocardial vascularized
cellular niche.
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CHAPTER 4
VASCULARIZED CARDIOMYOCYTE/FIBROBLAST CO-CULUTRE MODEL

4.1 Introduction
In the adult human myocardium, cardiomyocytes compose about 70% of myocardial
tissue volume but only 30% of the cell population [115]. The remaining cell population
is mainly composed of fibroblasts, followed by endothelial cells, smooth muscle cells,
pericytes, macrophages, and nerve cells [116-118]. The mentioned cell species are
organized in a very unique 3-dimensional architecture that optimizes mechanical and
electrical coupling enabling the myocardial tissue to sustain its contractile function. The
extracellular matrix (ECM) provides a scaffold in which all the cells are spatially
coordinated, as seen in Figure 4.1.

Figure 4.1 Graphical representation of the cardiomyocyte tubules in the native
myocardium [119].
Some of the principal challenges of generating a thick functional myocardial
construct are maintaining in vitro cardiomyocyte function and structure, recreating the
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intricate physical and chemical myocardial milieu, and vascularizing the dense construct.
In the past section, we were successful in vascularizing the chitosan scaffold with
endothelial cells. Hence, in this section, our aim is to impregnate the vascularized
chitosan scaffold with cardiomyocytes and fibroblasts to get closer to the in vitro
recreation of the cardiac cellular mosaic that can function as a myocardial tissue model.
Each cell in this cardiac mosaic performs vital functions that enable the optimum
functionality of the cardiomyocytes. For instance, as seen in Figure 4.2, each cell within
the myocardium is involved in the secretion of certain extracellular components
dependant on the mechanical and neurohormonal cues received by them.

Figure 4.2 Graphical representation of the diverse cellular milieu of the myocardium.
The cells have unique and overlapping contributions to the myocardium extracellular
constituents [120].
The cardiac fibroblasts produce the heart's interstitial ECM fibrillar proteins
which are predominantly Type I and III collagens and elastin [121]. The fibrous collagen
network maintains the structural integrity of the heart tissue as the cardiomyocytes
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shorten and the entire tissue contracts [122]. Fibroblasts have also been shown to assist in
electrical propagation of the wavefront [123]. Each cardiomyocyte is surrounded by
multiple fibroblasts, this close relation is vital for the mechanical and biochemical
communication between the two cell types. For instance, the secretion of stretch-induced
growth factors from cardiomyocytes activate fibroblasts cell proliferation and collagen
synthesis to counteract stress increases [124].

Figure 4.3 Diagrammatic representation of the connexin 43/45 gap junctions between
fibroblasts and cardiomyocytes that regulate the syncytial network within the
myocardium [125].
Cardiomyocytes form distinct layers that wrap around the contour of the heart.
Each cardiomyocyte is about 10-15um in diameter, 100um in length, and are connected
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end-to-end in both the longitudinal and transverse directions [117]. The maturation,
survival and function of cardiomyocytes are dependent on various physiological cues
including the physical and mechanical ECM cues which are relayed through the collagenintegrin-cytoskeletal relation [117]. Endothelial cells populate the complex vasculature
networks that perfuse the myocardial tissue. However, endothelial cells functions are not
confined to forming the capillary beds but they also affect cardiomyocyte survival,
contraction rhythmicity and cardiomyocyte organization via paracrine signaling.

Figure 4.4 Graphical representation of the paracrine and autocrine signaling that
constitute endothelial-cardiomyocyte interactions [96].
Simulating the in vivo myocardial cellular architecture with fibroblasts and
endothelial cells will present the cardiomyocytes with a physiological milieu that is closer
to the native environment and hence assist in retaining their function [126, 127]. The
intercellular interactions via gap junctions, cell-cell adhesion proteins and paracrine
signaling will aid in recreating the in vivo cellular communication that is vital in
maintaining optimum cardiomyocyte function and survival [128-130]. The 3-D
nanofibers will provide a physical matrix with interconnected spaces similar to the
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collagenous fibers in the native extracellular matrix. The pre-vascularization of the
construct will serve as an in vitro perfusion system to supply essential nutrients and
oxygen to the core of the scaffold. In addition, the 3-D vasculature will enable
endothelial-cardiomyocyte

intercellular

communication

that

affect

electrical

synchronization and contraction rhythmicity [126]. The pre-vascularization of the
construct might also help host vasculature to integrate faster into the construct as the
construct is already vascularized.
The main objective of this part of the research is to use the fibronectin
functionalized and vascularized chitosan nanofibers to create a tri-culture cardiomyocytefibroblast-endothelial in vitro cardiac tissue model.

4.2 Methods
4.2.1 Cardiomyocyte Mono- and Co-cultures on Chitosan Films and Nanofibers
For the co-culture studies (cardiomyocytes-fibroblasts or cardiomyocytes-endothelial
cells co-culture) in 2-D and 3-D culture systems, cells were seeded at the ratio of 1 to 1,
giving

a

total

initial

cell

number

(cardiomyocytes+fibroblasts

or

cardiomyocytes+endothelial cells) of ~50,000 cells/cm2 for 2-D and ~600,000 cells/cm2
for 3-D cultures. (For detailed methodology in terms of chitosan film and nanofiber
handling and cell seeding please refer to section 3.2)
4.2.2 Vascularized Cardiomyocyte-Fibroblasts Co-culture on Chitosan Nanofibers:
The chitosan nanofibers were neutralized, sterilized and incubation in fibronectin as
mentioned in Section 2.4. LSEC cells were seeded on the chitosan nanofibers at a density
of 125,000 cells/cm2 and cultured for 7 days to allow for tube formation. Cardiomyocytes
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and fibroblasts were seeded at a density of 125,000 cells/cm2 each and cultured for an
additional 7 days.
4.2.3 Immunohistochemsitry of Sarcomeric Actin and Connexin-43:
The samples were washed with PBS and fixed with 4% paraformaldehyde for 20 minutes
at room temperature. After washing with PBS, the samples were permeabilized in 0.2%
Triton X-100 in PBS for 10 minutes. The samples were then washed with PBS and
incubated in blocking buffer (PBS/10% FBS/1% BSA) for 30 minutes. The primary
antibody was then added and incubated for 60 minutes at room temperature. The samples
were washed with PBS and then incubated with the secondary antibody for 60 minutes.
The samples were then washed and examined with fluorescence microscopy (Nikon). The
primary antibodies used were mouse anti-vinculin (Millipore, 1:200 dilution), mouse
anti- -sarcomeric actin (Invitrogen, 1:50 dilution), and rabbit anti-connexin 43 (Sigma,
1:1000 dilution). The secondary antibodies used were donkey anti-mouse IgG, alexa fluor
488 and donkey anti-rabbit IgG, alexa fluor 594 (Invitrogen).
4.2.4 Calcium Transient Ion Staining:
Calcium indicator, fluo-4 AM (Invitrogen, F-14201) was reconstituted in sterile DMSO
to make a stock concentration of 2mM. Using cardiomyocyte media, the stock was
diluted to a final working concentration of 4µM. The cells were incubated in the 4µM
indicator media for 45 minutes at 37 oC. The cells were then washed with only
cardiomyocyte medium twice before incubating in cardiomyocyte medium for another 30
minutes at 37C. The indicator dye was excited using a 488nm laser. Videos of the
Calcium ion staining were captured using Nikon NIS-Elements Basic research_advanced.
Pseudocolor images of the Calcium ion fluorescence intensity were captured every
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150ms. The intensity of the calcium ion flux was determined by taking the average
intensity from 12 pixel image points from each frame and plotting the average intensity
over time.
4.3 Results
4.3.1 Co-culture Effect on Cardiomyocytes’ Morphology and Gap Junctions
Cardiomyocyte morphology and gap junction formation were monitored via sarcomeric
alpha-actin (SA-actin) and connexin-43 (Cx43) staining, respectively. Cardiomyocytes‟
SA-actin and Cx43 expression was examined on both fibronectin adsorbed chitosan films
(2-D) and fibronectin adsorbed chitosan nanofibers (3-D). In each condition,
cardiomyocytes were cultured in monocultures (cardiomyocytes only) and co-cultures
(cardiomyocytes-fibroblasts or cardiomyocytes-endothelial cells).

Figure 4.5 Morpholoy and phenotypic characteristics of primary neonatal
cardiomyocytes cultured on 2-dimensional Chitosan-fibronectin films. (A,D)
Cardiomyocyte monoculture, (B, E) Cardiomyocytes co-culture with fibroblasts, and (C,
F) cardiomyocytes with endothelial cells after 7 days incubation at 37°C and 10% CO2.
Cardiomyocytes were immunostained for α-sarcomeric actin (SA) and connecin-43
(Cx43) gap junction expression. 200X original magnification
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In the 2-D systems, the cardiomyocyte monoculture (Figure 4.5 A, D) exhibited
low expression of SA-actin and the cardiomyocytes lost their structural polarity and
acquired a rounded morphology. Gap junction protein Cx43 expression was minimal in
the monoculture system, resulting in isolated islands of contractions. In the fibroblasts coculture system (Figure 4.5 B, E), the cardiomyocytes maintained a highly polar
morphology and the SA-actin was strongly expressed along the axis of morphological
polarity. In addition, Cx43 expression was the highest in the fibroblasts co-culture which
enabled the cardiomyocytes to contract in a tissue-like synchronized manner. The
cardiomyocytes co-cultured with endothelial cells (Figure 4.5 C, F) demonstrated a
spherical morphology with lower levels of SA-actin and Cx43 expression than those in
the fibroblasts co-culture as well as isolated contractions.
To assess the chitosan nanofibers‟ potential as a cardiac tissue engineering
scaffold, the same cardiomyocyte monoculture and co-culture studies were performed on
the 3-D chitosan nanofibers. The cardiomyocyte monoculture (Figure 4.6 A, D) and
cardiomyocytes-endothelial cell co-culture (Figure 4.6 C, F) did not have any visible SAactin or Cx43 expression. The cardiomyocyte-fibroblast co-culture resulted in elongated
networks of contracting cardiomyocytes with the highest expression of SA-actin and
Cx43 (Figure 4.6 B, E).
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Figure 4.6 Morpholoy and phenotypic characteristics of primary neonatal
cardiomyocytes cultured in 3-dimensional chitosan electrospun nanofibrous matrices.
(A,D) Cardiomyocyte monoculture, (B, E) Cardiomyocytes co-culture with fibroblasts,
and (C, F) cardiomyocytes with endothelial cells after 19 days incubation at 37°C and
10% CO2. Cardiomyocytes were immunostained for α-sarcomeric actin (SA) and
connecin-43 (Cx43) gap junction expression. 200X original magnification

In both 2-D and 3-D cultures on chitosan scaffolds, cardiomyocyte-fibroblasts cocultures resulted in polarized cardiomyocyte morphology with high levels of SA-actin
and Cx43 expression over long-term culture periods. In addition, the fibroblasts cocultures demonstrated synchronized contractions involving large tissue-like cellular
networks, indicating the maintenance of long-term and stable function of cardiomyocytes
gap junctions. To our knowledge, the results of the present study provided the first
evidence that 3-D chitosan nanofibers can be used as a potential scaffold that can retain
cardiomyocyte morphology and function.
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4.3.2 Intracellular Calcium Ion Staining
The intracellular calcium ion flux staining was used to assess cardiomyocyte viability and
functionality. In the 2-D monoculture system, the cardiomyocyte lose their functionality
and morphology within 5-6 days. Figure 4.7 shows the pseudo color time-frame images
of the 2-D cardiomyocyte culture system.

The image analysis of the calcium flux

resulted in a frequency of 8 ± 2 contractions per minute.
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Figure 4.7 Pseudo-color intensity time frame images of intracellular calcium ion flux
stained using fluo-4-AM indicator in 2D monoculture of neonatal primary
cardiomyocytes cultured for 4 days. 200X original magnification

Figure 4.8 Frequency of intracellular calcium ion flux in the 2D monoculture of neonatal
primary cardiomyocytes after 4 days in culture.
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Figure 4.9 shows the pseudo color time-frame images of the 2-D cardiomyocytefibroblast co-culture system.

The image analysis of the calcium flux resulted in a

frequency of 30 ± 4 contractions per minute.
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Figure 4.9 Pseudo-color intensity time frame images of intracellular calcium ion flux
stained using fluo-4-AM indicator in 2D co-culture of neonatal primary cardiomyocytes
and fibroblasts cultured for 4 days. 200X original magnification

Figure 4.10 Frequency of intracellular calcium ion flux in the 2D co-culture of neonatal
primary cardiomyocytes and fibroblasts after 4 days in culture.
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Figure 4.11 shows the pseudo color time-frame images of the 3-D cardiomyocytefibroblast co-culture system.

The image analysis of the calcium flux resulted in a

frequency of 17 ± 3 contractions per minute.
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Figure 4.11 Pseudo-color intensity time frame images of intracellular calcium ion flux
stained using fluo-4-AM indicator in 3D co-culture of neonatal primary cardiomyocytes
and fibroblasts cultured for 7days. 200X original magnification

Figure 4.12 Frequency of intracellular calcium ion flux in the 3D co-culture of neonatal
primary cardiomyocytes and fibroblasts after 7 days in culture.
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Figure 4.13 shows the pseudo color time-frame images of the 3-D triculture
endothelial cell vascularized cardiomyocyte-fibroblast system. The image analysis of the
calcium flux resulted in a frequency of 28 ± 3 contractions per minute.

Figure 4.13 Pseudo-color intensity time frame images of intracellular calcium ion flow in
3D tri-culture system of endothelial cells, neonatal primary cardiomyocytes, and
fibroblasts after 7 day culture, 200X original magnification

Figure 4.14 Frequency of intracellular calcium ion flux in the 3D tri-culture of
endothelial cells, neonatal primary cardiomyocytes, and fibroblasts after 7 days in culture.
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From the pseudo-color image analysis it is important to observe the following:
1. In the 2D cardiomyocyte-fibroblast coculture system, the cardiomyocytes attained
an elongated morphology as compared to the mono-culture where the cells spread
out and displayed a flattened morphology.
2. In the 3D vascularized cardiomyocyte-fibroblast tri-culture system, the
cardiomyocytes formed a network of tubules that displayed rhythmic and
synchronized calcium ion fluxes.
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4.4 Discussion
Cardiac fibroblasts are the most abundant non-cardiomyocyte cells in the mature heart.
Their functions include deposition of the extracellular matrix (ECM), paracrine signaling
and propagation of the electrical stimuli. In this study, we used murine 3T3-J2 fibroblasts
cell line for cardiac co-cultures because of their easy access, propagation, and high
induction of epithelial cell functions (e.g. hepatocytes) [131-133]. The key feature of the
approach used in this research is the co-culturing of cardiomyocytes with fibroblasts
within a vascularized 3-D scaffold for long-term functionality of the cardiomyocytes.
To investigate the functionality and viability of cardiomyocytes, the expression of
contractile alpha-sarcomeric actin (SA) and cardiomyocyte gap junction protein
connexin-43 (Cx43) was used. SA-actin expression is solely found in cardiomyocytes and
is an indicative sign of cardiomyocyte functional maturity. Cx43 is the gap junction
protein that is mainly found in ventricular cardiomyocytes [134]. The Cx43 mediates
fibroblasts heterogeneous coupling, such as between cardiomyocytes and fibroblasts
[135]. These gap junctions with fibroblasts are known to propagate electrical stimuli for
100 m [134]. The results from both the 2-D and 3-D cultures indicate that fibroblasts
co-cultures resulted in the highest levels of SA-actin and Cx43 expression, suggesting
fibroblasts are essential in maintaining cardiomyocytes viability and function in vitro.
The observed cardiomyocyte co-culture enhancement effect can be attributed to
many of the fibroblasts‟ physiological functions in the native heart. Fibroblasts which
constitute 70% of the normal adult heart regulate the mechanical stability and structural
integrity of the cardiomyocytes via the dynamic generation of the extracellular matrix and
its turnover. From a histological view point, the myocytes laminae are enclosed in a
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network of endomysial collagen maintained by the fibroblasts [136]. Recent studies have
observed that the extracellular matrix produced by the fibroblasts maintain Cx43 since it
is regulated by heparin binding-epidermal growth factor (EGF) [137]. Hence, the results
demonstrate that fibroblasts should be an integral part of any cardiac regenerative therapy
as its role in providing a cardiomyocyte-compatible scaffold is of supreme importance.
The tubulogenesis of the endothelial cells on the chitosan scaffold recreates the
rich vasculature architecture that perfuses the native myocardial tissue. This technology
can be used as a platform to induce vascularization of various tissue regeneration
constructs or to build in vitro tissue models. The fact that cardiomyocytes are able to
survive and contract on chitosan nanofibers mats has never been reported before, to our
knowledge.
To assess cardiomyocyte contractility, transient calcium ion staining was
performed. Calcium is the most important ion involved in the excitation-contraction
coupling in cardiomyocytes. Briefly, for contraction to occur, intracellular calcium ion
concentration increases as calcium enters via depolarization-activated calcium
transmembrane channels. This flux of calcium ions initiate the release of more calcium
that is sequestered in the sarcoplasmic reticulum, Figure 4.15. The calcium binds to the
thin-filamentous protein troponinC which cooperatively activates the myofilaments
initiating contraction. For relaxation to occur, the intracellular calcium ions are depleted
via SR Ca-ATPase, Na/Ca exchange, Ca ATPase and mitochondrial Ca uniport [138].
Hence, intracellular calcium ion is a great method to assess cardiomyocyte functionality
since it is a vital regulator of cardiomyocyte contraction.
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Figure 4.15 The transport of calcium ions in ventricular myocytes. The inset graph
depicts the time course of a cardiomyocyte action potential, Ca ion transient
concentration and cardiomyocyte contraction in a rabbit ventricular myocyte at 37°C.
NCX: Na/Ca exchange; ATP: ATPase; PLB: phospholamban; SR: sarcoplasmic
reticulum (Image from Bers, 2002 [138])

The monoculture of cardiomyocytes on 2D lost their functionality and their
polarized morphology after 4 days. This is evident by the slow bursts of transient calcium
seen in the monocultures. The co-culture system with fibroblasts demonstrated how the
fibroblasts induce elongated cardiomyocyte morphology and a more rhythmic and more
frequent changes in intracellular calcium ion concentrations. The most important data set
is the cardiomyocyte-fibroblasts co-culture in the vascularized chitosan nanofibrous
scaffolds. It is clear that the cardiomyocytes have migrated and organized themselves into
myocyte tubules. The calcium flux in these elongated cardiomyocyte tubules is
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synchronized and have a periodicity that is established throughout the cardiomyocyte
tubular networks.

4.5 Conclusion
Results of this section of the research demonstrate that chitosan nanofibers can be used as
scaffolds for the development of 3-D cardiac tissue constructs. Primary neonatal
cardiomyocytes lost their viability and functionality in vitro when cultured alone. The
cardiac-fibroblasts co-culture model is a promising system for the maintenance of longterm survival and functionality of cardiomyocytes in vitro. The fibroblast co-culture
system also induces the cardiomyocytes to increase gap junction expression and attain
tubular morphology. These modifications in the cardiomyocytes encourage the cells to
function in syncytium as a 3D cardiac tissue model.
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CHAPTER 5
SUMMARY AND FUTURE STUDIES

The essence of this research endeavor was to create a cardiac tissue model. The avenue
pursued to reach this goal focused on recreating, as close as possible, the acellular and
cellular components of the cardiomyocyte in vivo cellular niche. The natural acellular
components include but are not limited to the collagen nanofiber scaffold and the
glycosaminoglycan hydrogel milieu. The natural cardiac cellular mosaic is mainly
composed of the dense endothelial cell vasculature bed that perfuses a cardiomyocyte:
fibroblast co-culture. In other words, the design inputs for the acellular and cellular
components of the engineered cardiac tissue model were dictated by the natural cardiac
tissue itself.
To satisfy the acellular design inputs, chitosan a cheap, non-toxic, biodegradable
and naturally derived polysaccharide was electrospun into nanofibers to recreate the
collagen nanofiber matrix. In addition, chitosan shares structural homology with the
glycosaminoglycans of the natural extracellular matrix. Therefore, the electrospun
chitosan nanofiber scaffold combined the physical collagenous nanofibrous architecture
with the structural glycosaminoglycan functionality into one scaffold.
To recreate the myocardial cellular mosaic, the chitosan nanofibers were
impregnated with endothelial cells and cultured for a week to allow the formation of a
network of endothelial tubes resembling the myocardial vasculature bed. The mechanism
of tubulogenesis induction by the fibronectin adsorbed chitosan nanofibers need further
detailed characterization. The extracellular matrix plays a critical role in synchronizing
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the signals that control angiogenesis. The literature provides evidence that suggests that
the extracellular matrix balances vascular morphogenesis and vascular regression as
shown in figure 5.1. Furthermore, integrin signal transduction pathways involving the
activation of Cdc42 and Rac1 initiate critical downstream signaling molecules that
control endothelial cell tube morphogenesis [139].

Figure 5.1 The genes and signaling pathways that are involved in the regulation of
vascular morphogenesis/regression balance.
More specifically, there are a number of published results that point to the vital
role of fibronectin receptors, α5β1, α4β1, and α9β1 in endothelial morphogenesis in the
formation of blood vessels [140]. Knocking out fibronectin or the integrin α5 subunit
results in substantial defects in the vascular phenotypes, pointing toward the essential role
of the fibronectin-integrin ligand/receptor interaction in vascularization [141]. An
interesting study to conduct would be the splicing of the fibronectin protein into smaller
peptide sequences to determine which particular sequence is involved in the induction of
vascular morphogenesis.
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In addition to fibronectin, the induction of endothelial tubulogenesis and
activation can be initiated via multiple extracellular matrix components such as different
types of collagens and fibrin matrices which have been shown to increase the production
of F-actin stress fibers and the disruption of VE-cadherin intercellular junction proteins
resulting in endothelial morphogenesis into tubules. On the other hand as seen in figure
5.2, laminin which is another component of the extracellular matrix does not induce the
formation of stress fibers and VE-cadherin intercellular junctions remain intact [142].

Figure 5.2 The effect of collagen type I, fibronectin,/fibrin, and lamini-1 on endothelial
tubulogenesis. The activation of Src and Rho signaling pathways and suppression of Rac
and PKA via collagen and fibronectin/fibrin interaction with α5β1 and αvβ3 integrin
receptors leads to the formation of actin stress fibers, the dissociation of the intercellular
junction proteins VE-cadherin and the tubular morphogenesis. However, laminin has the
effect of stopping endothelial morphogenic events and the stabilization of the tubules via
pericytes recruitment [142].

The cardiomyocytes and fibroblasts were then seeded onto the vascularized
chitosan scaffold to fully recapitulate the cellular composition of the myocardium. The
results clearly show that the vascularized cardiomyocyte-fibroblasts system have induced
the cardiomyocytes to communicate with each other to enable the formation of a network
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of cardiomyocyte tubules that function in syncytium. This research demonstrates the
importance of the fibroblasts co-culture in maintaining the functionality of primary
cardiomyocytes in vitro for up to four weeks; a requirement for any useful cardiac tissue
model. Furthermore, the endothelial tube formation on the chitosan nanofibers can be
used as a platform technology to provide vasculature architecture for numerous tissue
models.
There are a number of studies that show evidence of the pro-inflammatory
responses of chitosan as it attracts and activates macrophages. Feng et al. demonstrated
that oligochitosan (less than 10 saccharide residues) can be internalized by macrophages
via lectin receptors with mannose specificity [143]. Consequently, chitosan has a
stimulatory effect on the secretion of tumor necrosis factor-α, interleukin-1 β,
macrophage colony stimulating factor (GM-CSF), nitric oxide (NO), and interleukin-6 in
macrophages [144]. Huang et al. attributes chitosan‟s inflammatory response to its
cationic polyelectrolyte properties in attracting and activating macrophages [145]. This is
due to the finding that cationic groups cause irreversible and strong cell adhesion
invoking a strong inflammatory response [146]. These inflammatory responses can be
controlled by varying the degree of deacetylation of the chitosan being used or by
incorporating immune-modulating cells such as mesenchymal stem cells [147, 148].
The cardiac tissue model developed in this research showed promising results in
terms of attaining cardiomyocyte tubular morphology, synchronized contractility, and a
network of tubular endothelial cells. Future studies should focus on:
1. Building a mechanical stimulation bioreactor to condition the cardiac tissue model
with physiological loading.
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2. Assessing the swelling and stability of the chitosan nanofibers in human plasma.
3. Assessing the engraftment of the cardiac patch with in vivo animal studies.
4. Studying the pharmacology of cardiac drugs on the cardiac patch to determine its
feasibility as a diagnostics tool or drug screening tissue platform.
5. Examining cross-sections of the tissue-model to assess the migration and
infiltration of the cellular constructions within the scaffold. This can be done by
cryogenic freezing of the tissue-model and then cross-sectioning them into pieces
for histological staining. Another method would be the used of confocal
microscopy to examine the vertical planes of tissue-model
6. More detailed examination of the calcium ion staining to understand the cellular
functioning and how it correlates with certain features or shoulders of the calcium
ion wave.
7. Study why the xenogeneic tissue model allows the cardiomyocyte to maintain
functionality and viability.
In conclusion, this research has shown “proof-of-concept” of maintaining primary
cardiomyocyte viability and inducing tubular and tissue-like contractility via the
recreation of the acellular and cellular cardiomyocyte niche.
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